Down-regulation of CXCR4 expression by SDF-KDEL in CD34+ hematopoietic stem cells: An anti-human immunodeficiency virus strategy

Journal of Virological Methods

Volumn 161, Issue 1, 2009, Pages 30-37

  Zhang, Jiu Cong ^a   Sun, Li ^a   Nie, Qing He ^a   Huang, Chang Xing ^a   Jia, Zhan Sheng ^a   Wang, Jiu Ping ^a   Lian, Jian Qi ^a   Li, Xin Hong ^a   Wang, Ping Zhong ^a   Zhang, Ye ^a   Zhuang, Yan ^a   Sun, Yong Tao ^a   Bai, Xuefan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD34+ hHSC; CXCR4; Down regulation; Gene therapy; HIV 1; SDF 1

Indexed keywords

ANTIGEN P24; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; LENTIVIRUS VECTOR; RECOMBINANT PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE THERAPY;

ANTIGENS, CD34; CELLS, CULTURED; CHEMOKINE CXCL12; CULTURE MEDIA; DOWN-REGULATION; FLOW CYTOMETRY; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HIV CORE PROTEIN P24; HIV-1; HUMANS; INFANT, NEWBORN; LENTIVIRUS; RECEPTORS, CXCR4; TRANSDUCTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 67650682434     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.05.009     Document Type: Article

References (27)

1. Arenzana-Seisdedos F., and Parmentier M. Genetics of resistance to HIV infection: role of co-receptors and co-receptor ligands. Semin. Immunol. 18 (2006) 387-403
2. Balabanian K., Lagane B., Infantino S., Chow K.Y., Harriague J., Moepps B., Arenzana-Seisdedos F., Thelen M., and Bachelerie F. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280 (2005) 35760-35766
3. Bai X., Chen J.D., Yang A.G., Torti F., and Chen S.Y. Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines. Gene Ther. 5 (1998) 984-994
4. Burger J.A., and Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107 (2006) 1761-1767
5. Cairns J.S., and D'Souza M.P. Chemokines and HIV-1 second receptors: the therapeutic connection. Nat. Med. 4 (1998) 563-568
6. Chen J.D., Bai X., Yang A.G., Cong Y., and Chen S.Y. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy. Nat. Med. 3 (1997) 1110-1116
7. Clapham P.R., and McKnight A. HIV-1 receptors and cell tropism. Br. Med. Bull. 58 (2001) 43-59
8. Davis B.M., Humeau L., and Dropulic B. In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication. Mol. Ther. 9 (2004) 160-172
9. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., and Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381 (1996) 661-666
10. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S.C., Parmentier M., Collman R.G., and Doms R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85 (1996) 1149-1158
11. Emery D.W., Nishino T., Murata K., Fragkos M., and Stamatoyannopoulos G. Hematopoietic stem cell gene therapy. Int. J. Hematol. 75 (2002) 228-236
12. Feng Y., Leavitt M., Tritz R., Duarte E., Kang D., Mamounas M., Gilles P., Wong-Staal F., Kennedy S., Merson J., Yu M., and Barber J.R. Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5. Virology 276 (2000) 271-278
13. Hawley R.G. Progress toward vector design for hematopoietic stem cell gene therapy. Curr. Gene Ther. 1 (2001) 1-17
14. Hirsch M.S., Günthard H.F., Schapiro J.M., Brun-Vézinet F., Clotet B., Hammer S.M., Johnson V.A., Kuritzkes D.R., Mellors J.W., Pillay D., Yeni P.G., Jacobsen D.M., and Richman D.D. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin. Infect. Dis. 47 (2008) 266-285
15. Naldini L., Blömer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
16. Princen K., and Schols D. HIV chemokine receptor inhibitors as novel anti-HIV drugs. Cytokine Growth Factor Rev. 16 (2005) 659-677
17. Reed L.J., and Muench H. A simple method of estimating fifty percent end points. Am. J. Hyg. 27 (1938) 493-497
18. Santoro F., Vassena L., and Lusso P. Chemokine receptors as new molecular targets for antiviral therapy. New Microbiol. 27 (2004) 17-29
19. Scherr M., and Eder M. Gene transfer into hematopoietic stem cells using lentiviral vectors. Curr. Gene Ther. 2 (2002) 45-55
20. Schols D. HIV co-receptors as targets for antiviral therapy. Curr. Top. Med. Chem. 4 (2004) 883-893
21. Swainson L., Mongellaz C., Adjali O., Vicente R., and Taylor N. Lentiviral transduction of immune cells. Methods Mol. Biol. 415 (2008) 301-320
22. Sun L., Zhang Y., Huang C.X., Qu X.L., Zhang Y., Zhang J.C., Wei X., Zhuang Y., Zhai S., Peng M.J., Jiang H., Hao C.Q., Li Y.H., Lu J., Lian J.Q., Sun Y.T., and Bai X.F. Therapeutic effect of RANTES-KDEL on inhibition of HIV-1 in CD34(+) human hematopoietic stem cells (hHSC). J. Virol. Methods 154 (2008) 194-199
23. Tsibris A.M., and Kuritzkes D.R. Chemokine antagonists as therapeutics: focus on HIV-1. Annu. Rev. Med. 58 (2007) 445-459
24. Verhoeyen E., Nègre D., and Cosset F.L. Production of lentiviruses displaying "early-acting" cytokines for selective gene transfer into hematopoietic stem cells. Methods Mol. Biol. 434 (2008) 99-112
25. Vollweiler J.L., Zielske S.P., Reese J.S., and Gerson S.L. Hematopoietic stem cell gene therapy: progress toward therapeutic targets. Bone Marrow Transplant. 32 (2003) 1-7
26. Westby M., Smith-Burchnell C., Mori J., Lewis M., Mosley M., Stockdale M., Dorr P., Ciaramella G., and Perros M. Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry. J. Virol. 81 (2007) 2359-2371
27. Yang A.G., Bai X., Huang X.F., Yao C., and Chen S. Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 11567-11572